CD274 and hypothyroidism: In a case report of a nivolumab-related hypothyroidism, the anti-PD-L1 therapy suppressed the inhibitory PD-1/PD-L1 signals on follicular helper T cells (Th), leading to increased proliferation and subsequent overproduction of thyroid autoantibodies [16].